Search Results - Yongsheng Wang
- Showing 1 - 13 results of 13
-
1
Breast surgeons at the forefront: preserving lymph nodes for enhanced immunotherapy efficacy by Zhiqiang Shi, Qiuchen Zhao, Yongsheng Wang, Pengfei Qiu
Published 2025-07-01
Article -
2
-
3
-
4
-
5
-
6
Exploring the distribution of polymorphism across diverse breeds Worldwide in the bovine NR5A2 gene and its correlation with number of mature follicles and corpus albicans by Enhui Jiang, Xuanbo Chen, Taotao Yan, Yi Bi, Juanshan Zheng, Haiyu Zhao, Yongsheng Wang, Xiangchen Li, Xianyong Lan
Published 2024-12-01
Article -
7
-
8
Multicenter phase 1/2 study of onatasertib, a dual TORC1/2 inhibitor, combined with the PD-1 antibody toripalimab in advanced solid tumors by Pei Shu, Xiaoyu Li, Qi Zhou, Guiling Li, Keqiang Zhang, Li Yuan, Yixian Liu, Qiu Li, Yongsheng Wang, Hui Xie, Li Zheng
Published 2025-06-01
Article -
9
-
10
Straw and Green Manure Return Can Improve Soil Fertility and Rice Yield in Long-Term Cultivation Paddy Fields with High Initial Organic Matter Content by Hailin Zhang, Long Chen, Yongsheng Wang, Mengyi Xu, Weiwen Qiu, Wei Liu, Tingyu Wang, Shenglong Li, Yuanhang Fei, Muxing Liu, Hanjiang Nie, Qi Li, Xin Ni, Jun Yi
Published 2025-06-01
Article -
11
Real-world effectiveness of goserelin 10.8-mg compared to goserelin 3.6-mg in premenopausal and perimenopausal Chinese patients with hormone receptor positive breast cancer: a coho... by Yongsheng Wang, Xi Wang, Jiong Wu, Hong Liu, Jiuda Zhao, Jian Huang, Jianxia Liu, Youling Gong, Hao Wang, Huaqing Yang, Guorong Zou, Quchang Ouyang, Guoqin Jiang, Huijuan Liu, Sujie Ni, Binghe Xu, Jinming Yu
Published 2025-08-01
Article -
12
A CMTM6 Nanobody Overcomes EGFR‐TKI Resistance in Non‐Small Cell Lung Cancer by Lu Xia, Jichuan Wang, Hui Xue, Haimeng Li, Qinghua Li, Sen Qin, Chunyu Yu, Yanhua Liu, Yu Gao, Lingyun Li, Sudun Guan, Enrun Zheng, Feiya Suo, Lin He, Yongsheng Wang, Wenling Han, Yongfeng Shang, Yong Geng, Luyang Sun
Published 2025-07-01
Article -
13
Preclinical and first-in-human of purinostat mesylate, a novel selective HDAC I/IIb inhibitor, in relapsed/refractory multiple myeloma and lymphoma by Linyu Yang, Qiang Qiu, Jie Wang, Yi Wen, He Li, Rui Liang, Yunyu Feng, Fang Wang, Xiaojing Lin, Minghai Tang, Jianhong Yang, Heying Pei, Peng Zhao, Jishi Wang, Jin Xiang, Jia Miao, Li Zheng, Ke Tan, Yongsheng Wang, Yiguo Hu, Lijuan Chen, Weili Zhao, Ting Niu
Published 2025-06-01
Article